Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

To the Editor: The report by Ostrowsky et al. (May 10 issue) 1 provides evidence that active infection-control interventions can reduce or eliminate the transmission of vancomycin-resistant ...

A researcher team is collaborating with a Belgian industry partner to develop an antibody-based rapid VRE test capable of reliably detecting the expression of VanA and VanB. Enterococcus faecium is a ...

We studied the prevalence of recurrent vancomycin-resistant Enterococcus (VRE) bacteremia, predisposing factors, and strain relatedness during a 3 year period at our institution. Of 36 inpatients who ...

Antimicrobials with the potential to act as immune stimulators and overcome bacterial resistance are emerging as important alternative approaches to fighting antimicrobial resistance The novel ...

WEST LAFAYETTE, Ind. – Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated with ...

In a recent review published in the Microorganisms Journal, researchers reviewed existing data on the use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria, ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

HOUSTON -- (Aug. 12, 2019) -- To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can ...